Navigation Links
8-iso-13,14-dihydro-15-keto Prostaglandin F2alpha from Cayman Chemical

Products8-iso-13,14-dihydro-15-keto Prostaglandin F2alpha from Cayman Chemical
Company Cayman Chemical
Item 8-iso-13,14-dihydro-15-keto Prostaglandin F2alpha
Price $38.00
Description 8-iso-13,14-dihydro-15-keto Prostaglandin F2α (8-iso-13,14-dihydro-15-keto PGF2α) is a metabolite of the isoprostane, 8-isoprostane (8-iso PGF2α), in rabbits, monkeys and humans. 8-iso PGF2α is a PG-like product of non-specific lipid peroxidation. In both humans and monkeys, exogenously infused 8-isoprostane is converted primarily to metabolites having 2 or 4 carbon atoms removed from the top side chain by β-oxidation. A similar pattern is observed when tritiated 8-isoprostane is infused into rabbits. Early in the infusion (within 10 minutes) 8-iso-13,14-dihydro-15-keto PGF2α was a significant component of the metabolite profile, which was comprised mostly of dinor 8-isoprostane metabolites. 8-iso-13,14-dihydro-15-keto PGF2α weakly inhibits the U-46619 or collagen-induced aggregation of human platelets, although a number of the E-series isoprostanes are much more potent in this assay.
Info Cayman ChemicalCayman Chemical
Cayman Chemical Company
1180 East Ellsworth Road
Ann Arbor, Michigan 48108
Customer Service: (800) 364-9897
Fax Number: (734) 971-3640
Web Site: http://www.caymanchem.com/
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. 15(S)-15-methyl Prostaglandin F2alpha from Cayman Chemical
2. 15(R)-17-phenyl trinor Prostaglandin F2alpha isopropyl ester from Cayman Chemical
3. 8-iso Prostaglandin E2 from Cayman Chemical
4. Prostaglandin D2 from Cayman Chemical
5. Prostaglandin E1-d4 from Cayman Chemical
6. Prostaglandin E2 Luminex Standard from Cayman Chemical
7. Prostaglandin E2-d4 from Cayman Chemical
8. Prostaglandin E2-d4 from Cayman Chemical
9. Prostaglandin D2-d4 from Cayman Chemical
10. 6-keto Prostaglandin F1alpha-d4 from Cayman Chemical
11. Prostaglandin D2 , 5,6,8,9,12,14,15(n)-3H Conjugated/Tagged from GE Healthcare, formerly Amersham Biosciences
Formulation: Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide....
Mouse monoclonal [0.T.81] to Lac1 ( Abpromise for all tested applications). Antigen: Recombinant TrpE fusion protein containing full length E. coli Lac1....
Polyclonal Antibody to HADHB...
EDG-6 Lysate Source: Cell Lysate Application: Western Blotting Control Form: IgG...
Biology Products:
(Date:2/1/2017)... Massachusetts , February 1, 2017 IDTechEx ... events on emerging technology, announces the availability of a new report, ... Continue Reading ... ... in industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements of ... (IAM) lifecycle is comprised of a comprehensive set ... purpose of maintaining digital identities and providing a ... applications. There are significant number of programs opted ... to time by optimizing processes and changing policies. ...
(Date:1/19/2017)... 19, 2017 According to a new report published by ... - 2022," the global biometric sensor market is expected to garner $1.5 billion ... 2015, Asia-Pacific dominated the global market and contributed over ... Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... 22, 2017 Aethlon Medical, Inc. (Nasdaq: ... study that validated the ability of the Aethlon HemopurifierĀ® ... increased mortality in immune-suppressed sepsis patients and also contribute ... The objective of the study was to validate the ... virus (EBV) and Herpes Simplex virus 1 (HSV1) by ...
(Date:2/22/2017)... ... 22, 2017 , ... Pharma and biotech consulting firm ... Operating from Pennsideā€™s Zurich headquarters, Pennside Partners, GmbH, Mr. Perkins brings 14 years ... than a decade with leading market research firm, GfK. He began his pharma ...
(Date:2/22/2017)... RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017  United ... announced its financial results for the fourth quarter ... annual 2016 financial results reflect continued growth as ... $700 million," said Martine Rothblatt, Ph.D., United Therapeutics, ... strengthen our ability to develop and advance our ...
(Date:2/21/2017)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... months ended December 31, 2016. SQI is ... company that develops and commercializes proprietary technologies and products for ... ... milestones achieved in fiscal 2016," said Andrew Morris , ...
Breaking Biology Technology: